NASDAQ:AKCA - Akcea Therapeutics Earnings Date, Estimates & History Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Akcea Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $23.48 -1.86 (-7.34 %) (As of 07/16/2019 02:27 AM ET) Add Compare Today's Range$23.40Now: $23.48▼$25.578150-Day Range$21.04MA: $22.86▼$25.3452-Week Range$19.67Now: $23.48▼$40.75Volume172,611 shsAverage Volume224,255 shsMarket Capitalization$2.18 billionP/E RatioN/ADividend YieldN/ABeta1.57 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Earnings Akcea Therapeutics (NASDAQ:AKCA) Earnings History and Estimates Chart?The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.Akcea Therapeutics (NASDAQ:AKCA) Earnings EstimatesCurrent Year EPS Consensus Estimate: $-0.63 EPSNext Year EPS Consensus Estimate: $-1.02 EPSAkcea Therapeutics (NASDAQ AKCA) Earnings History by QuarterDateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails8/5/2019(Estimated) 5/8/2019Q1$1.24$0.34$0.34$171.40 million$163.82 millionViewListen2/26/2019Q4 2018($0.70)($0.79)($0.79)$17.76 million$10.20 millionViewListen11/5/2018Q3 2018($0.97)($0.73)($0.73)$20.52 million$19.24 millionViewN/A8/6/2018Q2 2018($0.75)($0.75)$14.24 million$18.30 millionViewN/A5/3/2018Q1 2018($0.37)($0.44)($0.44)$12.12 million$17.11 millionViewN/A2/26/2018Q4 2017($0.23)($0.26)($0.17)$15.48 million$18.04 millionViewN/A11/6/2017Q3 2017($0.21)($0.18)($0.09)$15.48 million$13.45 millionViewN/A8/8/2017Q2 2017($0.27)($0.13)$14.13 millionViewN/A(Earnings results data provided by Zacks Investment Research) This page was last updated on 7/16/2019 by MarketBeat.com StaffFeatured Article: What is the downside to momentum investing?
